Holger Pflicke

713 total citations
6 papers, 528 citations indexed

About

Holger Pflicke is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Holger Pflicke has authored 6 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 2 papers in Molecular Biology and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Holger Pflicke's work include Pancreatic and Hepatic Oncology Research (2 papers), Cancer Cells and Metastasis (2 papers) and RNA modifications and cancer (1 paper). Holger Pflicke is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Cancer Cells and Metastasis (2 papers) and RNA modifications and cancer (1 paper). Holger Pflicke collaborates with scholars based in United States, Germany and France. Holger Pflicke's co-authors include Michael Sixt, Kathrin Schumann, Jörg Renkawitz, Tim Lämmermann, Michele Weber, Julien Polleux, Joachim P. Spatz, Matthieu Piel, Udo Rudloff and Yaroslav Teper and has published in prestigious journals such as The Journal of Experimental Medicine, PLoS ONE and Nature Cell Biology.

In The Last Decade

Holger Pflicke

6 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Holger Pflicke United States	5	211	185	165	147	88	6	528
Alexander Leithner Austria	10	298 1.4×	216 1.2×	216 1.3×	299 2.0×	98 1.1×	12	751
Vera Auernheimer Germany	8	158 0.7×	211 1.1×	169 1.0×	70 0.5×	68 0.8×	10	472
Aaron J. Farrugia United Kingdom	8	192 0.9×	273 1.5×	358 2.2×	168 1.1×	45 0.5×	10	729
Jeff Wyckoff United States	5	227 1.1×	154 0.8×	228 1.4×	117 0.8×	55 0.6×	6	507
Robin J. Marjoram United States	11	174 0.8×	99 0.5×	175 1.1×	161 1.1×	70 0.8×	12	465
Vibeke Bertelsen Norway	13	198 0.9×	199 1.1×	351 2.1×	117 0.8×	67 0.8×	15	615
Kaitao Li United States	12	129 0.6×	139 0.8×	151 0.9×	227 1.5×	80 0.9×	14	524
Paulina Moreno‐Layseca United Kingdom	5	108 0.5×	192 1.0×	280 1.7×	62 0.4×	198 2.3×	7	571
Alon Oyler‐Yaniv United States	6	155 0.7×	151 0.8×	153 0.9×	303 2.1×	62 0.7×	8	564
Hanane Laklai France	8	279 1.3×	214 1.2×	280 1.7×	57 0.4×	65 0.7×	9	684

Countries citing papers authored by Holger Pflicke

Since Specialization

Citations

This map shows the geographic impact of Holger Pflicke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Holger Pflicke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Holger Pflicke more than expected).

Fields of papers citing papers by Holger Pflicke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Holger Pflicke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Holger Pflicke. The network helps show where Holger Pflicke may publish in the future.

Co-authorship network of co-authors of Holger Pflicke

This figure shows the co-authorship network connecting the top 25 collaborators of Holger Pflicke. A scholar is included among the top collaborators of Holger Pflicke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Holger Pflicke. Holger Pflicke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Bian, Yansong, Yaroslav Teper, Lesley A. Mathews Griner, et al.. (2019). Target Deconvolution of a Multikinase Inhibitor with Antimetastatic Properties Identifies TAOK3 as a Key Contributor to a Cancer Stem Cell–Like Phenotype. Molecular Cancer Therapeutics. 18(11). 2097–2110. 19 indexed citations

2.

Sorber, Rebecca, Yaroslav Teper, Abisola Abisoye-Ogunniyan, et al.. (2016). Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 as Enhancer of Proliferation and Invasion. PLoS ONE. 11(3). e0149833–e0149833. 22 indexed citations

3.

Jia, Jinping, Hemang Parikh, Wenming Xiao, et al.. (2013). An integrated transcriptome and epigenome analysis identifies a novel candidate gene for pancreatic cancer. BMC Medical Genomics. 6(1). 33–33. 28 indexed citations

4.

Miermont, Anne M., et al.. (2013). Abstract 5538: Direct inhibition of ERK1/2 by VTX-11e leads to increased induction of apoptosis in a subset of pancreatic cancer cell lines as compared to MEK1/2 inhibition by selumetinib (AZD6244).. Cancer Research. 73(8_Supplement). 5538–5538. 3 indexed citations

5.

Renkawitz, Jörg, Kathrin Schumann, Michele Weber, et al.. (2009). Adaptive force transmission in amoeboid cell migration. Nature Cell Biology. 11(12). 1438–1443. 210 indexed citations

6.

Pflicke, Holger & Michael Sixt. (2009). Preformed portals facilitate dendritic cell entry into afferent lymphatic vessels. The Journal of Experimental Medicine. 206(13). 2925–2935. 246 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact